PMID: 9526815Apr 4, 1998Paper

Use of niacin, statins, and resins in patients with combined hyperlipidemia

The American Journal of Cardiology
B G BrownJ D Brunzell

Abstract

Patients in the original Familial Atherosclerosis Treatment Study (FATS) cohort were subgrouped into those with triglyceride levels < or = 120 mg/dL (n = 26) and those with triglyceride levels > or = 190 mg/dL (n = 40). Their therapeutic responses to niacin plus colestipol, lovastatin plus colestipol, colestipol alone, or placebo were determined. Therapeutic response was also determined in the same 2 triglyceride subgroups (n = 12 and n = 27, respectively) of patients selected for low levels of high-density lipoprotein (HDL) cholesterol and coronary artery disease. These triglyceride criteria were chosen to identify patient subgroups with high likelihood of "pattern A" (normal-size low-density lipoprotein [LDL] particles and triglyceride < or = 120 mg/dL) or "pattern B" (small dense LDL and triglyceride > or = 190 mg/dL). Our findings in these small patient subgroups are consistent with the emerging understanding that coronary artery disease patients presenting with high triglyceride levels have lower HDL-C, smaller less buoyant LDL-C, and greater very low-density lipoprotein (VLDL) cholesterol and VLDL apolipoprotein B, and are more responsive to therapy as assessed by an increase in HDL-C and reduction in triglycerides, VLDL-...Continue Reading

Citations

Feb 24, 2007·Vascular Health and Risk Management·James M BackesPatricia A Howard
Nov 30, 2000·Current Treatment Options in Cardiovascular Medicine·H R Superko
Apr 11, 2003·Current Treatment Options in Cardiovascular Medicine·H. Robert Superko, Nicolas A. Chronos
Apr 18, 2001·Journal of Clinical Pharmacology·T D Dayspring
Oct 28, 2008·Current Cardiology Reports·Peter P Toth
Oct 30, 2013·International Journal of Clinical Practice·A BhargavaK V S N Yarlagadda
Sep 14, 1999·The American Journal of Medicine·C East
Sep 30, 2008·International Journal of Clinical Practice·A S Wierzbicki
Jun 20, 2008·International Journal of Clinical Practice·A S Wierzbicki
Mar 27, 2010·Journal of the American College of Cardiology·Pradeep NatarajanChristopher P Cannon
Jan 15, 2000·Journal of the American College of Cardiology·C J VaughanC T Basson
Jan 27, 2005·The Annals of Pharmacotherapy·James M Backes, Cheryl A Gibson
Sep 7, 2011·Therapeutic Advances in Cardiovascular Disease·Willibald HochholzerRobert P Giugliano
May 25, 2002·Heart Disease·Harry B Burke
Apr 23, 2008·Journal of Cardiovascular Pharmacology·Madiha Abdel-MaksoudJohn E Hokanson
Mar 30, 1999·Journal of Computer Assisted Tomography·T Kristensen, E W Olcott
Apr 7, 1999·Current Opinion in Cardiology·L J SemanE J Schaefer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.